漱玉平民(301017) - 2024 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2024 was ¥2,439,083,820.11, representing a 17.69% increase compared to ¥2,072,482,825.34 in the same period last year[4] - Net profit attributable to shareholders decreased by 83.72% to ¥10,508,208.55 from ¥64,553,649.73 year-on-year[4] - Basic and diluted earnings per share fell by 81.25% to ¥0.03, down from ¥0.16 in the same period last year[4] - The company achieved operating revenue of CNY 243.91 million in Q1 2024, representing a year-on-year increase of 17.69%[16] - The net profit attributable to shareholders decreased by 83.72% to CNY 10.51 million compared to the same period last year[16] - The net profit after deducting non-recurring gains and losses fell by 84.25% to CNY 9.51 million year-on-year[16] - Net profit for Q1 2024 was ¥11,377,582.93, a decrease of 82.9% from ¥66,526,141.25 in Q1 2023[30] - Earnings per share for Q1 2024 were ¥0.03, down from ¥0.16 in the same quarter last year[31] Cash Flow and Assets - The net cash flow from operating activities increased by 32.89% to ¥75,184,147.94, up from ¥56,575,234.08 in the previous year[4] - Cash received from operating activities totaled CNY 2,701,517,754.85, compared to CNY 2,216,545,326.15 in Q1 2023, reflecting a year-over-year increase of approximately 21.9%[34] - Total current assets amounted to approximately 5.71 billion CNY, an increase from 5.51 billion CNY at the beginning of the period[25] - Total assets reached approximately 9.56 billion CNY, up from 9.33 billion CNY at the beginning of the period[25] - Total cash and cash equivalents at the end of Q1 2024 amounted to CNY 946,508,791.12, up from CNY 1,021,875,903.46 at the end of Q1 2023[35] Liabilities and Equity - Total liabilities increased to ¥7,200,124,190.48 in Q1 2024 from ¥6,967,443,876.48 in Q1 2023[27] - Total equity attributable to shareholders of the parent company decreased to ¥2,268,028,613.50 from ¥2,292,063,021.84 year-over-year[27] - Minority interests increased to ¥96,617,961.98 in Q1 2024 from ¥74,169,508.13 in Q1 2023[27] - Long-term borrowings increased to approximately 749.83 million CNY from 658.18 million CNY[26] Operational Changes - The company plans to expand its logistics capabilities, which contributed to increased operational costs impacting net profit[9] - The company operates a total of 7,934 stores across several provinces, with 4,341 being direct-operated stores[17] - The company opened 22 new stores and closed 3 stores in Q1 2024, resulting in a net increase of 19 stores[18] - The company is focusing on a direct chain marketing model and steady expansion strategy in various provinces[17] Expenses and Margins - The gross margin decreased by 1.7 percentage points due to changes in healthcare policies affecting sales channels and product selection[16] - The company reported a significant increase in sales expenses, which rose to ¥523,927,303.51 from ¥424,345,254.99 in the previous year[30] - The company experienced a rise in management expenses, totaling ¥73,724,503.68 compared to ¥61,463,906.19 in the same period last year[30] Shareholder Actions - The top shareholder, Li Wenjie, holds 35.17% of the shares, with a total of 142,560,000 shares pledged[12] - The company plans to optimize product structure and enhance service quality to improve profitability amid market challenges[16] - The company has a total of 296,040,000 restricted shares, with specific release dates for certain shareholders[15] - The company approved a second batch of restricted stock grants on February 7, 2024, awarding 605,000 shares at a price of 8.675 CNY per share to 32 incentive recipients[19] - The company plans to repurchase shares with a total fund of no less than 40 million CNY and no more than 60 million CNY, with a maximum repurchase price of 18 CNY per share[20] - As of March 31, 2024, the company has repurchased a total of 2,602,588 shares, accounting for 0.64% of the total share capital, with a total transaction amount of approximately 38.12 million CNY[20] Investment Activities - Total cash inflow from investment activities was CNY 152,897,493.80, significantly higher than CNY 7,890,915.99 in the previous year[35] - The company reported a total cash outflow from investment activities of CNY 133,783,524.18, a decrease from CNY 270,591,408.28 in the previous year[35] - The company received CNY 3,150,000.00 from investments in Q1 2024, compared to CNY 1,664,000.00 in the previous year, indicating growth in investment activities[35] Debt and Financing - The company reported a significant increase in long-term payables by 4891.99% to ¥18,795,889.65, primarily due to financing leases[9] - The net cash flow from financing activities for Q1 2024 was CNY 22,304,637.52, compared to a negative cash flow of CNY -282,889,970.43 in Q1 2023, indicating a recovery in financing[35] - The cash flow from financing activities included CNY 358,540,000.00 received from borrowings, a significant increase from CNY 50,000,000.00 in Q1 2023[35] Inventory and Impairment - The company experienced a 327.50% increase in asset impairment losses, amounting to -¥7,969,615.48, due to increased inventory[9] - The company reported a significant increase in inventory, with current inventory valued at approximately 2.16 billion CNY, compared to 2.07 billion CNY at the beginning of the period[24]